-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RJT+Uh2hpEm9l5JVUwxSADCNd2n8/8hqt0lamMlBR4CRub7gKdSrOSNFRRvOqrHx JuQgeZD0lj+LsAgJZlZKew== 0001085146-10-000311.txt : 20100302 0001085146-10-000311.hdr.sgml : 20100302 20100301203538 ACCESSION NUMBER: 0001085146-10-000311 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100302 DATE AS OF CHANGE: 20100301 GROUP MEMBERS: MOG CAPITAL, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Fibrocell Science, Inc. CENTRAL INDEX KEY: 0000357097 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870458888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-60307 FILM NUMBER: 10647192 BUSINESS ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 484-713-6000 MAIL ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: ISOLAGEN INC DATE OF NAME CHANGE: 20020320 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /DE DATE OF NAME CHANGE: 19960330 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /CO DATE OF NAME CHANGE: 19921008 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MOG Capital, LLC CENTRAL INDEX KEY: 0001470642 IRS NUMBER: 203254923 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 2 RECTOR STREET, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10006 BUSINESS PHONE: 212-659-3874 MAIL ADDRESS: STREET 1: 2 RECTOR STREET, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10006 SC 13G 1 fibrocell13g.htm MOG CAPITAL LLC






UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. )

FIBROCELL SCIENCE, INC.
(Name of Issuer)

COMMON STOCK
(Title of Class of Securities)

315721100
(CUSIP Number)

October 13, 2009
(Date of Event Which Requires Filing of this Statement)
 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[]Rule 13d-1(b)
[X]Rule 13d-1(c)
[]Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be 'filed' for the purpose of Section 18 of the Securities Exchange Act of 1934 ('Act') or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
CUSIP No. 315721100
Person 1
 1. (a) Names of Reporting Persons.
MOG Capital, LLC
  (b) Tax ID
20-3254923
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  []
  (b)  []
 3. SEC Use Only . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 4. Citizenship or Place of Organization   New York, United States
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power  0
6.  Shared Voting Power 1,051,757
7. Sole Dispositive Power 0
8. Shared Dispositive Power 1,051,757

9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,051,757

 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 11. Percent of Class Represented by Amount in Row (9)  6.69%

 12. Type of Reporting Person (See Instructions)
BD

Item 1.
  (a) Name of Issuer
FIBROCELL SCIENCE, INC.
  (b) Address of Issuer's Principal Executive Offices
   405 Eagleview Boulevard, Exton, PA 19341
Item 2.
 (a) Name of Person Filing
MOG Capital, LLC
 (b) Address of Principal Business Office or, if none, Residence
2 Rector Street, 3rd Floor, New York, NY 10006
  (c) Citizenship
New York, United States
  (d) Title of Class of Securities
COMMON STOCK
  (e)CUSIP Number
315721100
 
Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c)
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940
(15 U.S.C 80a-8).
(e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act
(12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an investment company under section
3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);.
(k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K).If filing as a non-U.S. institution in accordance with 240.13d-1(b)(ii)(J), please specify the type of institution:
 
Item 4.Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 (a) Amount beneficially owned:  1,051,757
 (b) Percent of class:  6.69%
 (c)Number of shares as to which the person has:
  (i) Sole power to vote or to direct the vote 0
 (ii) Shared power to vote or to direct the vote  1,051,757
   (iii) Sole power to dispose or to direct the disposition of 0
  (iv) Shared power to dispose or to direct the disposition of 1,051,757
 
Person 2
 1. (a) Names of Reporting Persons.
Alphabet Partners, L.P.
  (b) Tax ID
26-1107125
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  []
  (b)  []
 3. SEC Use Only . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 4. Citizenship or Place of Organization   Delaware, United States
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power  0
6.  Shared Voting Power 1,051,757
7. Sole Dispositive Power 0
8. Shared Dispositive Power 1,051,757

9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,051,757

 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 11. Percent of Class Represented by Amount in Row (9)  6.69%

 12. Type of Reporting Person (See Instructions)
PN

Item 1.
  (a) Name of Issuer
FIBROCELL SCIENCE, INC.
  (b) Address of Issuer's Principal Executive Offices
   405 Eagleview Boulevard, Exton, PA 19341
Item 2.
 (a) Name of Person Filing
Alphabet Partners, L.P.
 (b) Address of Principal Business Office or, if none, Residence
2 Rector Street, 3rd Floor, New York, NY 10006
  (c) Citizenship
Delaware, United States
  (d) Title of Class of Securities
COMMON STOCK
  (e)CUSIP Number
315721100
 
Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c)
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940
(15 U.S.C 80a-8).
(e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act
(12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an investment company under section
3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);.
(k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K).If filing as a non-U.S. institution in accordance with 240.13d-1(b)(ii)(J), please specify the type of institution:
 
Item 4.Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 (a) Amount beneficially owned:  1,051,757
 (b) Percent of class:  6.69%
 (c)Number of shares as to which the person has:
  (i) Sole power to vote or to direct the vote 0
 (ii) Shared power to vote or to direct the vote  1,051,757
   (iii) Sole power to dispose or to direct the disposition of 0
  (iv) Shared power to dispose or to direct the disposition of 1,051,757
 
Person 3
 1. (a) Names of Reporting Persons.
Alphabet Advisors, LLC
  (b) Tax ID
26-1107229
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  []
  (b)  []
 3. SEC Use Only . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 4. Citizenship or Place of Organization   Delaware, United States
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power  0
6.  Shared Voting Power 1,051,757
7. Sole Dispositive Power 0
8. Shared Dispositive Power 1,051,757

9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,051,757

 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 11. Percent of Class Represented by Amount in Row (9)  6.69%

 12. Type of Reporting Person (See Instructions)
OO

Item 1.
  (a) Name of Issuer
FIBROCELL SCIENCE, INC.
  (b) Address of Issuer's Principal Executive Offices
   405 Eagleview Boulevard, Exton, PA 19341
Item 2.
 (a) Name of Person Filing
Alphabet Advisors, LLC
 (b) Address of Principal Business Office or, if none, Residence
2 Rector Street, 3rd Floor, New York, NY 10006
  (c) Citizenship
Delaware, United States
  (d) Title of Class of Securities
COMMON STOCK
  (e)CUSIP Number
315721100
 
Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c)
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940
(15 U.S.C 80a-8).
(e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act
(12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an investment company under section
3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);.
(k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K).If filing as a non-U.S. institution in accordance with 240.13d-1(b)(ii)(J), please specify the type of institution:
 
Item 4.Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 (a) Amount beneficially owned:  1,051,757
 (b) Percent of class:  6.69%
 (c)Number of shares as to which the person has:
  (i) Sole power to vote or to direct the vote 0
 (ii) Shared power to vote or to direct the vote  1,051,757
   (iii) Sole power to dispose or to direct the disposition of 0
  (iv) Shared power to dispose or to direct the disposition of 1,051,757
 
Person 4
 1. (a) Names of Reporting Persons.
Alphabet Management, LLC
  (b) Tax ID
26-1107179
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  []
  (b)  []
 3. SEC Use Only . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 4. Citizenship or Place of Organization   Delaware, United States
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power  0
6.  Shared Voting Power 1,051,757
7. Sole Dispositive Power 0
8. Shared Dispositive Power 1,051,757

9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,051,757

 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 11. Percent of Class Represented by Amount in Row (9)  6.69%

 12. Type of Reporting Person (See Instructions)
OO

Item 1.
  (a) Name of Issuer
FIBROCELL SCIENCE, INC.
  (b) Address of Issuer's Principal Executive Offices
   405 Eagleview Boulevard, Exton, PA 19341
Item 2.
 (a) Name of Person Filing
Alphabet Management, LLC
 (b) Address of Principal Business Office or, if none, Residence
2 Rector Street, 3rd Floor, New York, NY 10006
  (c) Citizenship
Delaware, United States
  (d) Title of Class of Securities
COMMON STOCK
  (e)CUSIP Number
315721100
 
Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c)
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940
(15 U.S.C 80a-8).
(e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act
(12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an investment company under section
3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);.
(k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K).If filing as a non-U.S. institution in accordance with 240.13d-1(b)(ii)(J), please specify the type of institution:
 
Item 4.Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 (a) Amount beneficially owned:  1,051,757
 (b) Percent of class:  0%
 (c)Number of shares as to which the person has:
  (i) Sole power to vote or to direct the vote 0
 (ii) Shared power to vote or to direct the vote  1,051,757
   (iii) Sole power to dispose or to direct the disposition of 0
  (iv) Shared power to dispose or to direct the disposition of 1,051,757
 
Person 5
 1. (a) Names of Reporting Persons.
Jason Adler
  (b) Tax ID
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  []
  (b)  []
 3. SEC Use Only . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 4. Citizenship or Place of Organization   United States
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power  0
6.  Shared Voting Power 1,051,757
7. Sole Dispositive Power 0
8. Shared Dispositive Power 1,051,757

9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,051,757

 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 11. Percent of Class Represented by Amount in Row (9)  6.69%

 12. Type of Reporting Person (See Instructions)
IN

Item 1.
  (a) Name of Issuer
FIBROCELL SCIENCE, INC.
  (b) Address of Issuer's Principal Executive Offices
   405 Eagleview Boulevard, Exton, PA 19341
Item 2.
 (a) Name of Person Filing
Jason Adler
 (b) Address of Principal Business Office or, if none, Residence
2 Rector Street, 3rd Floor, New York, NY 10006
  (c) Citizenship
United States
  (d) Title of Class of Securities
COMMON STOCK
  (e)CUSIP Number
315721100
 
Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c)
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940
(15 U.S.C 80a-8).
(e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act
(12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an investment company under section
3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);.
(k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K).If filing as a non-U.S. institution in accordance with 240.13d-1(b)(ii)(J), please specify the type of institution:
 
Item 4.Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 (a) Amount beneficially owned:  1,051,757
 (b) Percent of class:  6.69%
 (c)Number of shares as to which the person has:
  (i) Sole power to vote or to direct the vote 0
 (ii) Shared power to vote or to direct the vote  1,051,757
   (iii) Sole power to dispose or to direct the disposition of 0
  (iv) Shared power to dispose or to direct the disposition of 1,051,757
 
Person 6
 1. (a) Names of Reporting Persons.
Andrew Garnock
  (b) Tax ID
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  []
  (b)  []
 3. SEC Use Only . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 4. Citizenship or Place of Organization   United States
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power  0
6.  Shared Voting Power 1,051,757
7. Sole Dispositive Power 0
8. Shared Dispositive Power 1,051,757

9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,051,757

 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 11. Percent of Class Represented by Amount in Row (9)  6.69%

 12. Type of Reporting Person (See Instructions)
IN

Item 1.
  (a) Name of Issuer
FIBROCELL SCIENCE, INC.
  (b) Address of Issuer's Principal Executive Offices
   405 Eagleview Boulevard, Exton, PA 19341
Item 2.
 (a) Name of Person Filing
Andrew Garnock
 (b) Address of Principal Business Office or, if none, Residence
2 Rector Street, 3rd Floor, New York, NY 10006
  (c) Citizenship
United States
  (d) Title of Class of Securities
COMMON STOCK
  (e)CUSIP Number
315721100
 
Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c)
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940
(15 U.S.C 80a-8).
(e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act
(12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an investment company under section
3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);.
(k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K).If filing as a non-U.S. institution in accordance with 240.13d-1(b)(ii)(J), please specify the type of institution:
 
Item 4.Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 (a) Amount beneficially owned:  1,051,757
 (b) Percent of class:  6.69%
 (c)Number of shares as to which the person has:
  (i) Sole power to vote or to direct the vote 0
 (ii) Shared power to vote or to direct the vote  1,051,757
   (iii) Sole power to dispose or to direct the disposition of 0
  (iv) Shared power to dispose or to direct the disposition of 1,051,757
 
Item 5.Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.[ ].
 
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
MOG Capital, LLC is a proprietary trading firm owned 100% by Alphabet Partners, L.P. Alphabet Partners, L.P. (the "Partnership") is a private investment partnership, the general partner of which is Alphabet Advisors, LLC and investment manager of which is Alphabet Management, LLC. Alphabet Management, LLC is also the managing member of MOG Capital, LLC. Alphabet Advisors, LLC is the sole general partner of the Partnership and has the power to vote and dispose of the Common Stock. Accordingly, it may be deemed the "beneficial owner" of such Common Stock. As the
investment manager of the Partnership and managing member of MOG Capital, LLC, Alphabet
Management, LLC has the power to vote and and dispose of the Common Stock owned by MOG Capital, LLC and, accordingly, may be deemed the beneficial owner of the Common Stock. The Managing Members of Alphabet Management, LLC and Alphabet Advisors, LLC are Jason Adler and Andrew Garnock. Messrs. Adler and Garnoc k share investment management duties.
Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
NA
Item 8.Identification and Classification of Members of the Group
NA
Item 9.Notice of Dissolution of Group
NA
Item 10.Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 26, 2010
Date
Signature
By: Jason Adler
Title: Managing Member of Alphabet Management, LLC
and Alphabet Advisors, LLC
Name/Title
Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations
(See 18 U.S.C. 1001)
Advisor Consultant Network, Inc. Copyright © 2007-2010
 -----END PRIVACY-ENHANCED MESSAGE-----